⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALLR News
Allarity Therapeutics, Inc. Common Stock
New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
accessnewswire.com
VBIO
ALLR
Form 8-K
sec.gov
ALLR
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
globenewswire.com
ALLR
Form 8-K
sec.gov
ALLR
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
globenewswire.com
ALLR
Form 8-K
sec.gov
ALLR
Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development
globenewswire.com
ALLR
Form 8-K
sec.gov
ALLR
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
globenewswire.com
ALLR
Form 8-K
sec.gov
VBIO
ALLR